Sign In
Buy TMCI
$4.31
-0.0700 (-1.60%)
At Close: Jul 31, 2026
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm
05:25pm, Monday, 21'st Oct 2024
LOS ANGELES--(BUSINESS WIRE)--TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm.
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
09:45am, Monday, 14'th Oct 2024
PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
PONTE VEDRA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in t
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
04:15pm, Thursday, 22'nd Aug 2024
PONTE VEDRA, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Transcript
10:52pm, Tuesday, 06'th Aug 2024
Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Transcript
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
08:00pm, Tuesday, 06'th Aug 2024
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.20 per share a year ago.
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
04:05pm, Tuesday, 06'th Aug 2024
PONTE VEDRA, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgica
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
04:30pm, Thursday, 18'th Jul 2024
PONTE VEDRA, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
12:00pm, Sunday, 09'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI). Such investors are a
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
01:50pm, Friday, 07'th Jun 2024
NEW YORK , June 7, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are ad
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
04:28pm, Wednesday, 05'th Jun 2024
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI). Such inves
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
12:00pm, Saturday, 01'st Jun 2024
NEW YORK CITY, NY / ACCESSWIRE / June 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI). Such investors
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
06:10pm, Thursday, 30'th May 2024
NEW YORK , May 30, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are adv
Treace to Present at Truist Securities MedTech Conference
07:00am, Tuesday, 28'th May 2024
PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
04:50pm, Wednesday, 22'nd May 2024
NEW YORK , May 22, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ: TMCI). Such investors are ad
